Sentences with phrase «broad patents in»

One of the main issues with patent trolls, and broad patents in general, is that there are few efficient and economical ways to challenge a patent's validity.

Not exact matches

Enough that the brilliant minds behind Crispr - Cas9 — University of California at Berkeley's Jennifer Doudna, her academic partner Emmanuelle Charpentier of the Max Planck Institute for Infection Biology in Germany, and rival Broad Institute of MIT and Harvard scientist Feng Zhang — and the various biotechs affiliated with them are embroiled in an ugly, global patent spat over the rights to the tech.

When I first came across IPwe and Spangenberg's own initial, broad brushstroke blog post about the «misfit trolls, geeks and wonks» getting into the blockchain, I assumed he was amassing patents in the space to repeat his software strategy — and so did some patent experts whom I consulted.

But whatever the merits of this specific case — and however the three judges rule — there is a broader issue that speaks to the reason we have patent laws in the first place.

«Right now, patent trolls are manipulating the overly broad and poorly determined patent definition to win settlements and damages from tens of thousands of real American innovators,» Rep. Issa said in a statement.

The AIA made important improvements to the examination process and overall patent quality, but stakeholders remain concerned about patents with overly broad claims — particularly in the context of software.

Competitive advantages, including scale, existing patents on blockbuster drugs (such as Enbrel), broad geographical and product diversification, R&D, and a strong pipeline of drugs (16 compounds in Phase III trials) give this firm the strengths it needs to fight risks like competition, litigation, and regulation.

This can help you avoid the unnecessary costs inherent in filing a patent application that is too broad or even unsuccessful.

Venue reform was the one piece of comprehensive legislation that had broad support in Congress, so while the court's decision frees up capacity for patent reform advocates to tackle other problems with the patent system, the hard fights are still to come.

And the court has given states broad immunity from being sued in any court for money damages — for example, for infringing a patent or discriminating against older or disabled state employees — even though the Constitution limits this immunity only to suits in federal court by a citizen of a different state.

In contrast to his own Ph.D. training, Benzion continued, Babic's degree afforded a broad background that suited him extremely well to the unique and rigorous demands of work as a patent examiner.

For instance, your technical knowledge of a broad range of topics in your field, along with an ability to appreciate the potential applications of new ideas, may make you invaluable to investment firms, venture capitalists, and even patent lawyers trying to get a handle on the investment potential of new companies or technologies.

As Andy says on his info page, this is a «one - stop information resource to inventors, attorneys, artists, writers and editors, engineers and students, and any others interested in the broad fields of patents, trademarks and copyrights.»

Two new industries, biotechnology and multimedia, are getting very upset about entrepreneurs who file broad patents on ideas that others in the industry regard as old and well known.

Academics in the field are angry that the EPO approved such a broad patent.

After a prolonged legal battle, USPTO in February ruled that it wasn't obvious that UC's discovery would work in human and other eukaryotic cells, giving the Broad a distinct patent advantage.

UC, on behalf of several parties, has been in a pitched battle with the Broad Institute of Cambridge, Massachusetts, over CRISPR patents, and the new decision marks a sharp departure from the position of the U.S. Patent and Trademark Office (USPTO).

In a teleconference for the media held by UC, Doudna stressed that today's interference decision means USTPO will now move forward on her patent application and that it «likely» will issue, potentially forcing companies that want to use CRISPR to pay licensing fees to both Broad and UC.

Some agreements cover international use of CRISPR to make products, and if the UC CRISPR patent stands up to challenges in Europe, companies that banked on the Broad may have to enter more licensing agreements.

The U.S. Patent Trial and Appeal Board ruled today in favor of the Broad Institute in Cambridge, Massachusetts, in the initial legal step of a high stakes battle over who will control the valuable intellectual property linked to CRISPR, the powerful genome - editing tool.

Robert Cook - Deegan, a patent expert at Arizona State University in Tempe who is based in Washington, D.C., who has closely followed the CRISPR dispute, says the Broad likely will contest the EPO decision.

Broad beginning in December 2012 filed a dozen patents based on the eukaryotic use of CRISPR, and paid the U.S. Patent and Trademark Office (USPTO) to do a fast - track review.

This technological trend, which falls under the broader topic «Car2X,» is an area in which German companies have always been streets ahead as far as patenting is concerned.

In last week's filing, attorneys for the Broad Institute asked patent officials to remove two of its issued patents that focus on saCas9 from the original case, as well as two other patents (and a few affiliated claims in other patents) that describe techniques for enabling the CRISPR - Cas9 construct to target the nucleus of a eukaryotic celIn last week's filing, attorneys for the Broad Institute asked patent officials to remove two of its issued patents that focus on saCas9 from the original case, as well as two other patents (and a few affiliated claims in other patents) that describe techniques for enabling the CRISPR - Cas9 construct to target the nucleus of a eukaryotic celin other patents) that describe techniques for enabling the CRISPR - Cas9 construct to target the nucleus of a eukaryotic cell.

But UC contends it was «obvious» to extend the prokaryote work to eukaryotes, which is the heart of the Broad patents, and Broad contends that there was no reasonable expectation of success by people who had ordinary skill in the art.

Some have suggested Broad seemed to win the day, but Robert Cook - Deegan, who specializes in patent policy at Arizona State University in Tempe and attended the hearing, said he had no idea how the judges would rule and warned against overinterpreting their questions and responses.

The BRCA patents were due to expire in 2015 anyway, and most other similarly broad patents are also coming to the end of their lives.

EPO yesterday revoked a patent granted to the Broad for fundamental aspects of the technology, one of several of its patents facing opposition in Europe.

Doudna, Charpentier, and collaborators — who collectively are represented by UC — first filed a patent application in May 2012, whereas the Broad group did not file a patent claim until that December.

The patent just revoked was filed in December 2013, but to show that its claims predate competing publications and patent filings from UC and other groups, the Broad cites U.S. patent applications dating back to December 2012.

Lander is director of the Broad Institute and therefore someone with a very big dog in the patent fight.

Cell's decision to publish the article, despite the Broad's clear financial interest in the patent dispute, invited withering criticism.

And the same issue could threaten more of the Broad's intellectual property in Europe, says Jacob Sherkow, a patent specialist at New York Law School in New York City.

Broad's first patent application was rejected, he says, and Broad's response to USPTO — in particular, a declaration from Zhang — «was quite unfriendly and it questioned Jennifer's veracity and authenticity.»

To the surprise of many in the field, USPTO began issuing CRISPR patents to Broad in April 2014 before deciding on the UC Regents» earlier patent application.

The patent interference, in which University of California lawyers will probably claim that its scientists invented CRISPR gene - editing and also applied for a patent before Broad, will be hotly contested.

«If the Broad can't get the priority date that they want in their patents, things are just going to be really bad for them,» he says.

She notes that the decision doesn't threaten the many follow - on patents the Broad has filed for gene - editing technologies, including alternatives to the Cas9 enzyme used in the early CRISPR work.

But in Europe, a dispute that has gotten much less attention could derail several key Broad patents.

Patents are not meant to prevent research, but in practice who would risk a multimillion - dollar research investment in an area already fenced off by broad pPatents are not meant to prevent research, but in practice who would risk a multimillion - dollar research investment in an area already fenced off by broad patentspatents?

In addition to these broad categories, the Register lists 79 very specific classifications for the program, stating: «In order to be eligible for the Green Technology Pilot Program, the application must be classified in one of the U.S. patent classifications («USPCs») listed below at the time of examination.&raquIn addition to these broad categories, the Register lists 79 very specific classifications for the program, stating: «In order to be eligible for the Green Technology Pilot Program, the application must be classified in one of the U.S. patent classifications («USPCs») listed below at the time of examination.&raquIn order to be eligible for the Green Technology Pilot Program, the application must be classified in one of the U.S. patent classifications («USPCs») listed below at the time of examination.&raquin one of the U.S. patent classifications («USPCs») listed below at the time of examination.»

Judging from the firestorm of criticism, «The Heroes of CRISPR» falls short on a number of issues, beginning with this awkward money - tinged paradox: If the CRISPR story (and science in general) is such a beautiful ensemble activity, why is there only one name on the Broad Institute's patent?

(Broad, Editas, and the other parties in the patent dispute refused to discuss the details.)

But the U.S. Patent and Trademark Office issued a patent in 2014 to Feng Zhang of the Broad Institute, which filed its application after Berkeley but requested expedited considerPatent and Trademark Office issued a patent in 2014 to Feng Zhang of the Broad Institute, which filed its application after Berkeley but requested expedited considerpatent in 2014 to Feng Zhang of the Broad Institute, which filed its application after Berkeley but requested expedited consideration.

As a result, he argues, the patent is too broad to be permitted under «disclosure rules» that specify how closely something must be described in a patent.

Tan, and patent professionals in similar positions, aim to make their clients» intellectual property protection as broad and robust as possible.

Yet the Classen case shows that broad patent claims can survive in court.

But very broad patents have posed a problem in the technology field, where some firms amass vast portfolios of patents bought up from inventors and look for targets to sue.

The patented discovery comes from Novocell's recognized research & development programs to commercialize pluripotent stem cells for broad research and therapeutic uses, in particular, for an innovative cell therapy for the treatment of diabetes.

Previously serving in the General Counsel role for both public and private life sciences companies as well as the Compliance Officer and Corporate Secretary for a public company, Christina has broad strategic «in - house» experience, including extensive experience with intellectual property and partnership transactions, financings, patent portfolio development, compliance and other legal matters.